Bifidobacterium breve 30 capsules (3 billion CFU/capsule)

25.00

The use of Bifidobacterium breve probiotics has shown an anti-inflammatory effect, positive results in adjusting the microbial composition1 in patients with Celiac disease, resulting in decreased constipation-related symptoms2. B. breve is also used as a prevention for gastrointestinal symptom3 and rebalance the intestinal microbiota in infants and children4.

Description

Dosage: 3 billion CFU per capsule

Capsules per order: 30 capsules

Instructions: 1 capsule daily (morning)

Citations:

  1. Quagliariello A. et al. Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. Nutrients. 2016 Oct 22;8(10). pii:E660. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084046/
  2. Primec M. et al. Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-a and short-chain fatty acids. Clinical Nutrition 2018, 1-9. https://pubmed.ncbi.nlm.nih.gov/29960810/
  3. Aloisio I. et al. Three-Month Feeding Integration with Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns. Frontiers in Nutrition, May 2018, art. 39. https://www.frontiersin.org/articles/10.3389/fnut.2018.00039/full
  4. Mogna L. et al. Capability of the Two Microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to Colonize the Intestinal Microbiota of Children J Clin Gastroenterol, 2014. Suppl. 1, November/December, Vol. 48. https://pubmed.ncbi.nlm.nih.gov/25291125/